Report Detail
Global (United States, European Union and China) Alpha- Antitrypsin Deficiency Treatment Market Research Report 2019-2025
- RnM3373566 |
- 02 May, 2019 |
- Global |
- 128 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Alpha- Antitrypsin Deficiency Treatment is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alpha- Antitrypsin Deficiency Treatment.
This report studies the global market size of Alpha- Antitrypsin Deficiency Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Alpha- Antitrypsin Deficiency Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Adverum Biotechnologies, Inc.
Alnylam Pharmaceuticals, Inc.
Applied Genetic Technologies Corporation
Arrowhead Pharmaceuticals, Inc.
Carolus Therapeutics, Inc.
Cevec Pharmaceuticals GmbH
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Editas Medicine, Inc.
Grifols, S.A.
Inhibrx
Intellia Therapeutics, Inc.
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
Kamada Ltd.
Polyphor Ltd.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
Sangamo BioSciences, Inc.
Market Segment by Product Type
CT-2009
POL-6014
ARO-AAT
ALNAAT-02
Others
Market Segment by Application
Clinic
Hospital
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Alpha- Antitrypsin Deficiency Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Alpha- Antitrypsin Deficiency Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Alpha- Antitrypsin Deficiency Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 CT-2009
- 1.3.3 POL-6014
- 1.3.4 ARO-AAT
- 1.3.5 ALNAAT-02
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2019-2025)
- 1.4.2 Clinic
- 1.4.3 Hospital
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size
- 2.1.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue 2014-2025
- 2.1.2 Global Alpha- Antitrypsin Deficiency Treatment Sales 2014-2025
- 2.2 Alpha- Antitrypsin Deficiency Treatment Growth Rate by Regions
- 2.2.1 Global Alpha- Antitrypsin Deficiency Treatment Sales by Regions 2014-2019
- 2.2.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Alpha- Antitrypsin Deficiency Treatment Sales by Manufacturers
- 3.1.1 Alpha- Antitrypsin Deficiency Treatment Sales by Manufacturers 2014-2019
- 3.1.2 Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Alpha- Antitrypsin Deficiency Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Alpha- Antitrypsin Deficiency Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Alpha- Antitrypsin Deficiency Treatment Price by Manufacturers
- 3.4 Key Manufacturers Alpha- Antitrypsin Deficiency Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Alpha- Antitrypsin Deficiency Treatment Market
- 3.6 Key Manufacturers Alpha- Antitrypsin Deficiency Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 CT-2009 Sales and Revenue (2014-2019)
- 4.1.2 POL-6014 Sales and Revenue (2014-2019)
- 4.1.3 ARO-AAT Sales and Revenue (2014-2019)
- 4.1.4 ALNAAT-02 Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Type
- 4.3 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type
- 4.4 Alpha- Antitrypsin Deficiency Treatment Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Alpha- Antitrypsin Deficiency Treatment Sales by Application
6 United States
- 6.1 United States Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Company
- 6.2 United States Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type
- 6.3 United States Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application
7 European Union
- 7.1 European Union Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Company
- 7.2 European Union Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type
- 7.3 European Union Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application
8 China
- 8.1 China Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Company
- 8.2 China Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type
- 8.3 China Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Company
- 9.2 Rest of World Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type
- 9.3 Rest of World Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application
- 9.4 Rest of World Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Countries
- 9.4.1 Rest of World Alpha- Antitrypsin Deficiency Treatment Sales by Countries
- 9.4.2 Rest of World Alpha- Antitrypsin Deficiency Treatment Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Adverum Biotechnologies, Inc.
- 10.1.1 Adverum Biotechnologies, Inc. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.1.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.1.5 Adverum Biotechnologies, Inc. Recent Development
- 10.2 Alnylam Pharmaceuticals, Inc.
- 10.2.1 Alnylam Pharmaceuticals, Inc. Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.2.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
- 10.3 Applied Genetic Technologies Corporation
- 10.3.1 Applied Genetic Technologies Corporation Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.3.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.3.5 Applied Genetic Technologies Corporation Recent Development
- 10.4 Arrowhead Pharmaceuticals, Inc.
- 10.4.1 Arrowhead Pharmaceuticals, Inc. Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.4.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.4.5 Arrowhead Pharmaceuticals, Inc. Recent Development
- 10.5 Carolus Therapeutics, Inc.
- 10.5.1 Carolus Therapeutics, Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.5.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.5.5 Carolus Therapeutics, Inc. Recent Development
- 10.6 Cevec Pharmaceuticals GmbH
- 10.6.1 Cevec Pharmaceuticals GmbH Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.6.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.6.5 Cevec Pharmaceuticals GmbH Recent Development
- 10.7 Dicerna Pharmaceuticals, Inc.
- 10.7.1 Dicerna Pharmaceuticals, Inc. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.7.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.7.5 Dicerna Pharmaceuticals, Inc. Recent Development
- 10.8 Digna Biotech, S.L.
- 10.8.1 Digna Biotech, S.L. Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.8.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.8.5 Digna Biotech, S.L. Recent Development
- 10.9 Editas Medicine, Inc.
- 10.9.1 Editas Medicine, Inc. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.9.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.9.5 Editas Medicine, Inc. Recent Development
- 10.10 Grifols, S.A.
- 10.10.1 Grifols, S.A. Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Alpha- Antitrypsin Deficiency Treatment
- 10.10.4 Alpha- Antitrypsin Deficiency Treatment Product Introduction
- 10.10.5 Grifols, S.A. Recent Development
- 10.11 Inhibrx
- 10.12 Intellia Therapeutics, Inc.
- 10.13 International Stem Cell Corporation
- 10.14 Ionis Pharmaceuticals, Inc.
- 10.15 Kamada Ltd.
- 10.16 Polyphor Ltd.
- 10.17 ProMetic Life Sciences Inc.
- 10.18 rEVO Biologics, Inc.
- 10.19 Sangamo BioSciences, Inc.
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Alpha- Antitrypsin Deficiency Treatment Sales Channels
- 11.2.2 Alpha- Antitrypsin Deficiency Treatment Distributors
- 11.3 Alpha- Antitrypsin Deficiency Treatment Customers
12 Market Forecast
- 12.1 Global Alpha- Antitrypsin Deficiency Treatment Sales and Revenue Forecast 2019-2025
- 12.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Type
- 12.3 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Application
- 12.4 Alpha- Antitrypsin Deficiency Treatment Forecast by Regions
- 12.4.1 Global Alpha- Antitrypsin Deficiency Treatment Sales Forecast by Regions 2019-2025
- 12.4.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Alpha- Antitrypsin Deficiency Treatment . Industry analysis & Market Report on Alpha- Antitrypsin Deficiency Treatment is a syndicated market report, published as Global (United States, European Union and China) Alpha- Antitrypsin Deficiency Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Alpha- Antitrypsin Deficiency Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
